Glivec and Ambisome drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glivec (imatinib mesylate) and Ambisome (amphotericin b). Common drug interactions include malaise among females and drug hypersensitivity among males.

The phase IV clinical study analyzes what interactions people have when they take Glivec and Ambisome. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Glivec?

Glivec has active ingredients of imatinib mesylate. eHealthMe is studying from 17,777 Glivec users. Check the latest studies of Glivec.

What is Ambisome?

Ambisome has active ingredients of amphotericin b. eHealthMe is studying from 7,934 Ambisome users. Check the latest studies of Ambisome.

On Jul, 20, 2026

15 people who take Glivec and Ambisome together, and have interactions are studied.

What are the common drug interactions of Glivec and Ambisome, by gender? *:

female:

Malaise (a feeling of general discomfort or uneasiness)
Pyrexia (fever)
Cryptococcosis (potentially fatal fungal disease)
Dementia (madness)
Folliculitis (infection of hair root)
Herpes zoster
Hypofibrinogenaemia (a decrease in plasma fibrogen level)
Hypokalaemia (low potassium)
Liver disorder (liver diseases)
Mallory-weiss syndrome (gastro-oesophageal laceration syndrome refers to bleeding from tears)

male:

Drug hypersensitivity
Febrile neutropenia (fever with reduced white blood cells)
Rotavirus infection
Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
Stomatitis (inflammation of mucous membrane of mouth)
Upper respiratory tract infection
Conjunctivitis (pink eye)
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)
Device related infection
Constipation

What are the common drug interactions of Glivec and Ambisome, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Drug hypersensitivity
Abdominal pain
Anal inflammation
Catheter site infection (infection at the site of insertion)
Febrile neutropenia (fever with reduced white blood cells)
Gastrointestinal viral infection (virus infection of gastrointestinal tract)
Hypokalaemia (low potassium)
Nausea (feeling of having an urge to vomit)
Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)

10-19:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Alanine aminotransferase increased
Anaemia (lack of blood)
Arthralgia (joint pain)
Aspartate aminotransferase increased
Cardiac failure
Febrile neutropenia (fever with reduced white blood cells)
Hypoxia (low oxygen in tissues)
Leukocytosis (increased white blood cells)
Neutropenia (an abnormally low number of neutrophils)

20-29:

n/a

30-39:

n/a

40-49:

Renal failure (kidney dysfunction)

50-59:

Cryptococcosis (potentially fatal fungal disease)
Dementia (madness)
Folliculitis (infection of hair root)
Herpes zoster
Hypofibrinogenaemia (a decrease in plasma fibrogen level)
Hypokalaemia (low potassium)
Liver disorder (liver diseases)
Malaise (a feeling of general discomfort or uneasiness)
Mallory-weiss syndrome (gastro-oesophageal laceration syndrome refers to bleeding from tears)
Oedema (fluid collection in tissue)

60+:

Acute respiratory failure
Blood creatine phosphokinase increased
White blood cell count increased
Drug ineffective
Chills (felling of cold)
Circulatory collapse
Diarrhoea
Hyperkalaemia (damage to or disease of the kidney)
Malaise (a feeling of general discomfort or uneasiness)
Oedema peripheral (superficial swelling)

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 11 people, 73.33%
Leukaemia (blood or bone marrow cancer): 9 people, 60.00%
High Blood Pressure: 2 people, 13.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 13.33%
Joint Pain: 1 person, 6.67%
Insomnia (sleeplessness): 1 person, 6.67%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 6.67%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 1 person, 6.67%
Depression: 1 person, 6.67%
Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Glivec and Ambisome?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously